Tokyo, Japan

Masahiro Bougauchi

This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Pharma Corporation. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Bougauchi. Retrieved from https://idiyas.com/inventor/masahiro-bougauchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahiro Bougauchi: Innovator in Pharmaceutical Chemistry

Introduction

Masahiro Bougauchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Bougauchi holds 2 patents, with his latest invention focusing on phenoxypropylamine compounds. This invention relates to a phenoxypropylamine compound of the formula (I), which exhibits selective affinity and antagonistic activity against the 5-HT receptor. Additionally, it demonstrates 5-HT reuptake inhibitory activity, making it a potential candidate for antidepressants that can quickly express an anti-depressive effect.

Career Highlights

He is currently associated with Mitsubishi Pharma Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work is pivotal in advancing treatments for mental health conditions.

Collaborations

Some of his notable coworkers include Akira Nishiyama and Takanobu Kuroita, who collaborate with him on various projects within the company.

Conclusion

Masahiro Bougauchi's work in developing phenoxypropylamine compounds showcases his dedication to improving mental health treatments. His contributions to the field are invaluable and highlight the importance of innovation in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…